Felix Y. Feng

Active 1997–2025

Also published as
Felix Y Feng
327
Papers
48,340
Citations
111
h-index
307
i10-index

Citations

Citations per year for Felix Y. Feng1991: 1 citations1998: 4 citations1999: 8 citations2000: 5 citations2001: 11 citations2002: 8 citations2003: 5 citations2004: 6 citations2005: 3 citations2006: 14 citations2007: 15 citations2008: 17 citations2009: 30 citations2010: 32 citations2011: 50 citations2012: 70 citations2013: 98 citations2014: 177 citations2015: 314 citations2016: 521 citations2017: 617 citations2018: 680 citations2019: 2,257 citations2020: 2,563 citations2021: 2,744 citations2022: 2,140 citations2023: 1,674 citations2024: 2,849 citations2025: 1,388 citations2026: 36 citations1992–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,513 citing papers, 26% of this breakdownChina: 3,559 citing papers, 16.8% of this breakdownUnited Kingdom: 1,227 citing papers, 5.8% of this breakdownCanada: 1,011 citing papers, 4.8% of this breakdownGermany: 971 citing papers, 4.6% of this breakdownItaly: 931 citing papers, 4.4% of this breakdownFrance: 646 citing papers, 3% of this breakdownAustralia: 612 citing papers, 2.9% of this breakdownSpain: 521 citing papers, 2.5% of this breakdownNetherlands: 510 citing papers, 2.4% of this breakdownSwitzerland: 498 citing papers, 2.3% of this breakdownJapan: 440 citing papers, 2.1% of this breakdown
0%26%Other 22.4%

Fields

  • Medicine50.5%
  • Biochemistry, Genetics and Molecular Biology43.6%
  • Immunology and Microbiology1.4%
  • Computer Science0.9%
  • Health Professions0.8%
  • Neuroscience0.6%
  • Other2.2%

Topics

  • Prostate Cancer Treatment and Research10.4%
  • Cancer-related molecular mechanisms research7%
  • Prostate Cancer Diagnosis and Treatment5.9%
  • RNA modifications and cancer4.3%
  • Circular RNAs in diseases2.9%
  • Cancer Genomics and Diagnostics2.8%
  • Other66.7%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. The Lancet Commission on prostate cancer: planning for the surge in cases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anwar R. Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard R. Soule, Matthew R. Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Liping Xie - The Lancet 2024 cited by 643

  3. The landscape of long noncoding RNAs in the human transcriptome

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 2,890

  4. Long noncoding RNAs in cancer metastasis

    Authors: , , , , - Nature reviews. Cancer 2021 cited by 711

  5. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Small - Journal of Clinical Oncology 2018 cited by 812

  6. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono - New England Journal of Medicine 2015 cited by 2,187

  7. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Chou, Haolong Li, Rajdeep Das, Hui Li, Ruhollah Moussavi-Baygi, Hani Goodarzi, Luke A. Gilbert, Primo N. Lara, Christopher P. Evans, Theodore C. Goldstein, Joshua M. Stuart, Scott A. Tomlins, Daniel E. Spratt, R. Keira Cheetham, Donavan T. Cheng, Kyle Kai‐How Farh, Julian Gehring, Jörg Hakenberg, Arnold Liao, Philip G. Febbo, John Shon, Brad Sickler, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, Felix Y. Feng - Cell 2018 cited by 759

  8. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

    Authors: , , , , , , , , , , , , , , - Nature Communications 2022 cited by 277

  9. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 787

  10. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandy Liu, Alexander G. Balogh, Pamela D. Randolph-Jackson, David L. Schwartz, Michael R. Girvigian, Naoyuki G. Saito, Adam Raben, Rachel A. Rabinovitch, Khalil Katato, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad - npj Digital Medicine, npj Digit. Medicine 2022 cited by 197

  11. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 609

  12. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , - Nature 2014 cited by 962

  13. The DNA methylation landscape of advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, M. Yvonne Kim, Lawrence Fong, Daniel E. Spratt, Todd M. Morgan, Rohit Bose, Franklin W. Huang, Hui Li, Lisa N. Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A. Asangani, Shahneen Sandhu, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phillip G. Febbo, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Wilbert Zwart, J Costello, Jianhua Luo, Scott A. Tomlins, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Luke A. Gilbert, Paul C. Boutros, Kyle Kai‐How Farh, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, David A. Quigley, Felix Y. Feng - Nature Genetics 2020 cited by 353

  14. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy

    Authors: , , , , - Cancer Discovery 2020 cited by 293

  15. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki and 18 more - European Journal of Cancer 2023 cited by 157

  16. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maximillian Diehn, Søren M. Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S. Antonarakis, Tamara L. Lotan, Alejandro Berlín, Shankar Siva, Piet Ost, Phuoc T. Tran - Journal of Clinical Oncology 2022 cited by 243

  17. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 192

  18. Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - NEJM Evidence 2023 cited by 120

  19. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , - Nature 2019 cited by 298

  20. Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 155

  21. ONECUT2 is a driver of neuroendocrine prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felix Y. Feng, Leigh Ellis, Theodorus van der Kwast, Alejandro Berlín, Marianne Koritzinsky, Paul C. Boutros, Amina Zoubeidi, Himisha Beltran, Yuzhuo Wang, Housheng Hansen He - Nature Communications 2019 cited by 244

  22. Widespread and Functional RNA Circularization in Localized Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Lacombe, Yves Fradet, Bernard Têtu, Stanley K. Liu, Felix Y. Feng, Xue Wu, Yang Shao, Malgorzata A. Komor, Cenk Sahinalp, Colin C. Collins, Youri Hoogstrate, Mark de Jong, Remond J.A. Fijneman, Teng Fei, Guido Jenster, Theodorus van der Kwast, Robert G. Bristow, Paul C. Boutros, Housheng Hansen He - Cell 2019 cited by 696

  23. Racial/Ethnic Disparities in Genomic Sequencing

    Authors: , , , , , , - JAMA Oncology 2016 cited by 361

  24. Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 409